The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Equine Pharmaceuticals and Supplements Market Research Report 2025
Synopsis
The global market for Equine Pharmaceuticals and Supplements was valued at US$ 1253 million in the year 2024 and is projected to reach a revised size of US$ 1698 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Equine Pharmaceuticals and Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Pharmaceuticals and Supplements.
The Equine Pharmaceuticals and Supplements market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Equine Pharmaceuticals and Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Pharmaceuticals and Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Segment by Type
Pharmaceuticals
Supplements
Segment by Application
Thoroughbred Horse
Other Types of Horses
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Equine Pharmaceuticals and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Equine Pharmaceuticals and Supplements was valued at US$ 1253 million in the year 2024 and is projected to reach a revised size of US$ 1698 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Equine Pharmaceuticals and Supplements are medicines or supplements that are specially used to supplement nutrition and cure diseases.
Global Equine Pharmaceuticals and Supplements key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share over 45%, followed by Europe, and Asia-Pacific, both have a share over 30 percent.
In terms of product, Pharmaceuticals is the largest segment, with a share about 80%. And in terms of application, the largest application is Thoroughbred Horse, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Equine Pharmaceuticals and Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Pharmaceuticals and Supplements.
The Equine Pharmaceuticals and Supplements market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Equine Pharmaceuticals and Supplements market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Pharmaceuticals and Supplements manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
Segment by Type
Pharmaceuticals
Supplements
Segment by Application
Thoroughbred Horse
Other Types of Horses
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equine Pharmaceuticals and Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Equine Pharmaceuticals and Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Equine Pharmaceuticals and Supplements Market Overview
1.1 Product Definition
1.2 Equine Pharmaceuticals and Supplements by Type
1.2.1 Global Equine Pharmaceuticals and Supplements Market Value Comparison by Type (2024 VS 2031)
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Equine Pharmaceuticals and Supplements by Application
1.3.1 Global Equine Pharmaceuticals and Supplements Market Value by Application (2024 VS 2031)
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Global Equine Pharmaceuticals and Supplements Market Size Estimates and Forecasts
1.4.1 Global Equine Pharmaceuticals and Supplements Revenue 2020-2031
1.4.2 Global Equine Pharmaceuticals and Supplements Sales 2020-2031
1.4.3 Global Equine Pharmaceuticals and Supplements Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Equine Pharmaceuticals and Supplements Market Competition by Manufacturers
2.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2020-2025)
2.2 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Equine Pharmaceuticals and Supplements Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Equine Pharmaceuticals and Supplements, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Product Type & Application
2.7 Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Date of Enter into This Industry
2.8 Global Equine Pharmaceuticals and Supplements Market Competitive Situation and Trends
2.8.1 Global Equine Pharmaceuticals and Supplements Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players Market Share by Revenue
2.8.3 Global Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Equine Pharmaceuticals and Supplements Market Scenario by Region
3.1 Global Equine Pharmaceuticals and Supplements Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2020-2031
3.2.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2020-2025
3.2.2 Global Equine Pharmaceuticals and Supplements Sales by Region: 2026-2031
3.3 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2020-2031
3.3.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2020-2025
3.3.2 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2026-2031
3.4 North America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.4.1 North America Equine Pharmaceuticals and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Equine Pharmaceuticals and Supplements Sales by Country (2020-2031)
3.4.3 North America Equine Pharmaceuticals and Supplements Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.5.1 Europe Equine Pharmaceuticals and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2031)
3.5.3 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Pharmaceuticals and Supplements Market Facts & Figures by Region
3.6.1 Asia Pacific Equine Pharmaceuticals and Supplements Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2020-2031)
3.6.3 Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.7.1 Latin America Equine Pharmaceuticals and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2020-2031)
3.7.3 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2031)
3.8.3 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2020-2031)
4.1.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2020-2025)
4.1.2 Global Equine Pharmaceuticals and Supplements Sales by Type (2026-2031)
4.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2031)
4.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2020-2031)
4.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Type (2020-2025)
4.2.2 Global Equine Pharmaceuticals and Supplements Revenue by Type (2026-2031)
4.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2031)
4.3 Global Equine Pharmaceuticals and Supplements Price by Type (2020-2031)
5 Segment by Application
5.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2020-2031)
5.1.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2020-2025)
5.1.2 Global Equine Pharmaceuticals and Supplements Sales by Application (2026-2031)
5.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2031)
5.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2020-2031)
5.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Application (2020-2025)
5.2.2 Global Equine Pharmaceuticals and Supplements Revenue by Application (2026-2031)
5.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2031)
5.3 Global Equine Pharmaceuticals and Supplements Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Company Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Company Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zoetis Equine Pharmaceuticals and Supplements Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Bayer Animal Health
6.4.1 Bayer Animal Health Company Information
6.4.2 Bayer Animal Health Description and Business Overview
6.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
6.4.5 Bayer Animal Health Recent Developments/Updates
6.5 Elanco Animal Health
6.5.1 Elanco Animal Health Company Information
6.5.2 Elanco Animal Health Description and Business Overview
6.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Portfolio
6.5.5 Elanco Animal Health Recent Developments/Updates
6.6 Dechra Veterinary Products
6.6.1 Dechra Veterinary Products Company Information
6.6.2 Dechra Veterinary Products Description and Business Overview
6.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Portfolio
6.6.5 Dechra Veterinary Products Recent Developments/Updates
6.7 CEVA
6.7.1 CEVA Company Information
6.7.2 CEVA Description and Business Overview
6.7.3 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CEVA Equine Pharmaceuticals and Supplements Product Portfolio
6.7.5 CEVA Recent Developments/Updates
6.8 Virbac
6.8.1 Virbac Company Information
6.8.2 Virbac Description and Business Overview
6.8.3 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Virbac Equine Pharmaceuticals and Supplements Product Portfolio
6.8.5 Virbac Recent Developments/Updates
6.9 Norbrook Equine
6.9.1 Norbrook Equine Company Information
6.9.2 Norbrook Equine Description and Business Overview
6.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Product Portfolio
6.9.5 Norbrook Equine Recent Developments/Updates
6.10 Kyoritsu Seiyaku
6.10.1 Kyoritsu Seiyaku Company Information
6.10.2 Kyoritsu Seiyaku Description and Business Overview
6.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Portfolio
6.10.5 Kyoritsu Seiyaku Recent Developments/Updates
6.11 Vetoquinol
6.11.1 Vetoquinol Company Information
6.11.2 Vetoquinol Description and Business Overview
6.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Product Portfolio
6.11.5 Vetoquinol Recent Developments/Updates
6.12 Protexin Healthcare
6.12.1 Protexin Healthcare Company Information
6.12.2 Protexin Healthcare Description and Business Overview
6.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Portfolio
6.12.5 Protexin Healthcare Recent Developments/Updates
6.13 Audevard
6.13.1 Audevard Company Information
6.13.2 Audevard Description and Business Overview
6.13.3 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Audevard Equine Pharmaceuticals and Supplements Product Portfolio
6.13.5 Audevard Recent Developments/Updates
6.14 Ouro Fino Saude
6.14.1 Ouro Fino Saude Company Information
6.14.2 Ouro Fino Saude Description and Business Overview
6.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Portfolio
6.14.5 Ouro Fino Saude Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Pharmaceuticals and Supplements Industry Chain Analysis
7.2 Equine Pharmaceuticals and Supplements Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Pharmaceuticals and Supplements Production Mode & Process Analysis
7.4 Equine Pharmaceuticals and Supplements Sales and Marketing
7.4.1 Equine Pharmaceuticals and Supplements Sales Channels
7.4.2 Equine Pharmaceuticals and Supplements Distributors
7.5 Equine Pharmaceuticals and Supplements Customer Analysis
8 Equine Pharmaceuticals and Supplements Market Dynamics
8.1 Equine Pharmaceuticals and Supplements Industry Trends
8.2 Equine Pharmaceuticals and Supplements Market Drivers
8.3 Equine Pharmaceuticals and Supplements Market Challenges
8.4 Equine Pharmaceuticals and Supplements Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Equine Pharmaceuticals and Supplements Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Equine Pharmaceuticals and Supplements Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Equine Pharmaceuticals and Supplements Market Competitive Situation by Manufacturers in 2024
Table 4. Global Equine Pharmaceuticals and Supplements Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Equine Pharmaceuticals and Supplements Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Equine Pharmaceuticals and Supplements, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Product Type & Application
Table 12. Global Key Manufacturers of Equine Pharmaceuticals and Supplements, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Units)
Table 18. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2025)
Table 19. Global Equine Pharmaceuticals and Supplements Sales by Region (2026-2031) & (K Units)
Table 20. Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2026-2031)
Table 21. Global Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2025)
Table 23. Global Equine Pharmaceuticals and Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2026-2031)
Table 25. North America Equine Pharmaceuticals and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 27. North America Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 28. North America Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Equine Pharmaceuticals and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 32. Europe Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 33. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Equine Pharmaceuticals and Supplements Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Equine Pharmaceuticals and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2020-2025)
Table 51. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Type (2026-2031)
Table 52. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2020-2025)
Table 53. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2026-2031)
Table 54. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2020-2025)
Table 57. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2026-2031)
Table 58. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Type (2020-2025)
Table 59. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Type (2026-2031)
Table 60. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2020-2025)
Table 61. Global Equine Pharmaceuticals and Supplements Sales (K Units) by Application (2026-2031)
Table 62. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2020-2025)
Table 63. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2026-2031)
Table 64. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Equine Pharmaceuticals and Supplements Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2020-2025)
Table 67. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2026-2031)
Table 68. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Application (2020-2025)
Table 69. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Application (2026-2031)
Table 70. Boehringer Ingelheim Company Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Merck Animal Health Company Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Merck Animal Health Equine Pharmaceuticals and Supplements Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Zoetis Company Information
Table 81. Zoetis Description and Business Overview
Table 82. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Zoetis Equine Pharmaceuticals and Supplements Product
Table 84. Zoetis Recent Developments/Updates
Table 85. Bayer Animal Health Company Information
Table 86. Bayer Animal Health Description and Business Overview
Table 87. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Bayer Animal Health Equine Pharmaceuticals and Supplements Product
Table 89. Bayer Animal Health Recent Developments/Updates
Table 90. Elanco Animal Health Company Information
Table 91. Elanco Animal Health Description and Business Overview
Table 92. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Elanco Animal Health Equine Pharmaceuticals and Supplements Product
Table 94. Elanco Animal Health Recent Developments/Updates
Table 95. Dechra Veterinary Products Company Information
Table 96. Dechra Veterinary Products Description and Business Overview
Table 97. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product
Table 99. Dechra Veterinary Products Recent Developments/Updates
Table 100. CEVA Company Information
Table 101. CEVA Description and Business Overview
Table 102. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. CEVA Equine Pharmaceuticals and Supplements Product
Table 104. CEVA Recent Developments/Updates
Table 105. Virbac Company Information
Table 106. Virbac Description and Business Overview
Table 107. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Virbac Equine Pharmaceuticals and Supplements Product
Table 109. Virbac Recent Developments/Updates
Table 110. Norbrook Equine Company Information
Table 111. Norbrook Equine Description and Business Overview
Table 112. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Norbrook Equine Equine Pharmaceuticals and Supplements Product
Table 114. Norbrook Equine Recent Developments/Updates
Table 115. Kyoritsu Seiyaku Company Information
Table 116. Kyoritsu Seiyaku Description and Business Overview
Table 117. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product
Table 119. Kyoritsu Seiyaku Recent Developments/Updates
Table 120. Vetoquinol Company Information
Table 121. Vetoquinol Description and Business Overview
Table 122. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Vetoquinol Equine Pharmaceuticals and Supplements Product
Table 124. Vetoquinol Recent Developments/Updates
Table 125. Protexin Healthcare Company Information
Table 126. Protexin Healthcare Description and Business Overview
Table 127. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Protexin Healthcare Equine Pharmaceuticals and Supplements Product
Table 129. Protexin Healthcare Recent Developments/Updates
Table 130. Audevard Company Information
Table 131. Audevard Description and Business Overview
Table 132. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Audevard Equine Pharmaceuticals and Supplements Product
Table 134. Audevard Recent Developments/Updates
Table 135. Ouro Fino Saude Company Information
Table 136. Ouro Fino Saude Description and Business Overview
Table 137. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product
Table 139. Ouro Fino Saude Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Equine Pharmaceuticals and Supplements Distributors List
Table 143. Equine Pharmaceuticals and Supplements Customers List
Table 144. Equine Pharmaceuticals and Supplements Market Trends
Table 145. Equine Pharmaceuticals and Supplements Market Drivers
Table 146. Equine Pharmaceuticals and Supplements Market Challenges
Table 147. Equine Pharmaceuticals and Supplements Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of Equine Pharmaceuticals and Supplements
Figure 2. Global Equine Pharmaceuticals and Supplements Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Equine Pharmaceuticals and Supplements Market Share by Type: 2024 & 2031
Figure 4. Pharmaceuticals Product Picture
Figure 5. Supplements Product Picture
Figure 6. Global Equine Pharmaceuticals and Supplements Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Equine Pharmaceuticals and Supplements Market Share by Application: 2024 & 2031
Figure 8. Thoroughbred Horse
Figure 9. Other Types of Horses
Figure 10. Global Equine Pharmaceuticals and Supplements Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Equine Pharmaceuticals and Supplements Market Size (2020-2031) & (US$ Million)
Figure 12. Global Equine Pharmaceuticals and Supplements Sales (2020-2031) & (K Units)
Figure 13. Global Equine Pharmaceuticals and Supplements Average Price (USD/Unit) & (2020-2031)
Figure 14. Equine Pharmaceuticals and Supplements Report Years Considered
Figure 15. Equine Pharmaceuticals and Supplements Sales Share by Manufacturers in 2024
Figure 16. Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Equine Pharmaceuticals and Supplements Players: Market Share by Revenue in Equine Pharmaceuticals and Supplements in 2024
Figure 18. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2031)
Figure 21. North America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2031)
Figure 22. U.S. Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2031)
Figure 25. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2031)
Figure 26. Germany Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2020-2031)
Figure 33. China Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Taiwan Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Indonesia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Thailand Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Malaysia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Philippines Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2031)
Figure 44. Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. U.A.E Equine Pharmaceuticals and Supplements Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Equine Pharmaceuticals and Supplements by Type (2020-2031)
Figure 54. Global Revenue Market Share of Equine Pharmaceuticals and Supplements by Type (2020-2031)
Figure 55. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Equine Pharmaceuticals and Supplements by Application (2020-2031)
Figure 57. Global Revenue Market Share of Equine Pharmaceuticals and Supplements by Application (2020-2031)
Figure 58. Global Equine Pharmaceuticals and Supplements Price (USD/Unit) by Application (2020-2031)
Figure 59. Equine Pharmaceuticals and Supplements Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
